Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment

We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg...

Full description

Bibliographic Details
Main Authors: M. Benucci, A. Damiani, A. Arena, M. Infantino, M. Manfredi, F. Li Gobbi
Format: Article
Language:English
Published: PAGEPress Publications 2016-12-01
Series:Reumatismo
Subjects:
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/911
id doaj-f747ab7a402b45bd8a88f6200a2480a0
record_format Article
spelling doaj-f747ab7a402b45bd8a88f6200a2480a02020-11-24T23:02:41ZengPAGEPress PublicationsReumatismo0048-74492240-26832016-12-0168316316510.4081/reumatismo.2016.911724Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatmentM. Benucci0A. Damiani1A. Arena2M. Infantino3M. Manfredi4F. Li Gobbi5Rheumatology Unit, S. Giovanni di Dio Hospital, FirenzeRheumatology Unit, S. Giovanni di Dio Hospital, FirenzeNuclear Medicine Unit, New Hospital, PratoImmunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, FirenzeImmunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, FirenzeRheumatology Unit, S. Giovanni di Dio Hospital, FirenzeWe observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies.http://www.reumatismo.org/index.php/reuma/article/view/911Spondylodiscitisetanerceptankylosing spondylitis.
collection DOAJ
language English
format Article
sources DOAJ
author M. Benucci
A. Damiani
A. Arena
M. Infantino
M. Manfredi
F. Li Gobbi
spellingShingle M. Benucci
A. Damiani
A. Arena
M. Infantino
M. Manfredi
F. Li Gobbi
Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
Reumatismo
Spondylodiscitis
etanercept
ankylosing spondylitis.
author_facet M. Benucci
A. Damiani
A. Arena
M. Infantino
M. Manfredi
F. Li Gobbi
author_sort M. Benucci
title Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
title_short Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
title_full Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
title_fullStr Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
title_full_unstemmed Aseptic HLA B27-positive spondylodiscitis: decreased 18F-FDG uptake after etanercept treatment
title_sort aseptic hla b27-positive spondylodiscitis: decreased 18f-fdg uptake after etanercept treatment
publisher PAGEPress Publications
series Reumatismo
issn 0048-7449
2240-2683
publishDate 2016-12-01
description We observed a 69-year old man suffering from HLA B27 ankylosing spondylitis with persistent night back pain. 18F-FDG-PET/CT showed an increased metabolism at the level of the spinal space of L2-L3, L3-L4 with increased uptake compatible with spondylodiscitis. He started therapy with etanercept 50 mg/week. After six months of treatment repeated testing showed no uptake of the discs and vertebral bodies.
topic Spondylodiscitis
etanercept
ankylosing spondylitis.
url http://www.reumatismo.org/index.php/reuma/article/view/911
work_keys_str_mv AT mbenucci aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment
AT adamiani aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment
AT aarena aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment
AT minfantino aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment
AT mmanfredi aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment
AT fligobbi aseptichlab27positivespondylodiscitisdecreased18ffdguptakeafteretanercepttreatment
_version_ 1725635560655028224